Xiaoming Zha

8PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 27, 2026
Stained region lymph node biopsy for axillary restaging after neoadjuvant systemic therapy in node-positive breast cancer: a cohort study.

|Feb 17, 2026
KDM6A alternative splicing induced by 25(OH)D inhibits breast cancer cell stemness through repressing TRAP1 transcription.

Lingjun Ma, Xingye Sheng, Lexin Wang

|Mar 31, 2025
Omission of axillary lymph node dissection in patients with breast cancer with axillary pathological complete response confirmed by stained region lymph node biopsy after neoadjuvant systemic therapy (SrLNB study): study protocol for a single-arm, single-centre, phase-II trial.

Lingjun Ma, Rui Chen, Mingyu Wang

|Sep 11, 2024
Omission of sentinel lymph node biopsy in patients with clinically axillary lymph node-negative early breast cancer (OMSLNB): protocol for a prospective, non-inferiority, single-arm, phase II clinical trial in China.

Xuan Li, Lexin Wang, Yuanyuan Wang

|May 09, 2024
A 3'-pre-tRNA-derived small RNA tRF-1-Ser regulated by 25(OH)D promotes proliferation and stemness by inhibiting the function of MBNL1 in breast cancer.

Xinyu Wan, Wenjie Shi, Lingjun Ma

|Aug 16, 2021
Can axillary surgery be omitted in patients with breast pathologic complete response after neoadjuvant systemic therapy for breast cancer? A real-world retrospective study in China.

Rui Chen, Shuo Li, Yan Li

Pageof 2

Frequent Collaborators

3 joint publications

Jue Wang

2 joint publications

Lingjun Ma

1 joint publications

Rui Chen

1 joint publications

Yan Li